Additional studies in progress advise that ARV-825 may also be effective in improving the response to estrogen deprivation (aromatase inhibition), another ingredient of standard of care in ER+ breast cancer. Celastrol was recognized as a Myb inhibitor that suppressed C/EBPβ action and repressed AML cell proliferation within a Main mouse https://edwardp887cnx0.ssnblog.com/profile